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Abstract
Determining the genetic diversity ofM. tuberculosis strains allows identification of the dis-
tinctMycobacterium tuberculosis genotypes responsible for tuberculosis in different re-
gions. Several studies have reported the genetic diversity ofM. tuberculosis strains in
Mexico, but little information is available from the state of Jalisco. Therefore, the aim of this
study was to determine the genetic diversity ofMycobacterium tuberculosis clinical isolates
fromWestern Mexico. Sixty-eightM. tuberculosis isolates were tested for susceptibility to
first-line drugs using manual Mycobacteria Growth Indicator Tube method and genotyped
using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) pattern
analyses. Forty-seven (69.1%) isolates were grouped into 10 clusters and 21 isolates dis-
played single patterns by spoligotyping. Three of the 21 single patterns corresponded to or-
phan patterns in the SITVITWEB database, and 1 new type that contained 2 isolates was
created. The most prevalent lineages were T (38.2%), Haarlem (17.7%), LAM (17.7%),
X (7.4%), S (5.9%), EAI (1.5%) and Beijing (1.5%). Six (12.8%) of the clustered isolates
were MDR, and type 406 of the Beijing family was among the MDR isolates. Seventeen
(26.2%) isolates were grouped into 8 clusters and 48 isolates displayed single patterns by
IS6110-RFLP. Combination of IS6110-RFLP and spoligotyping reduced the clustering rate
to 20.0%. The results show that T, Haarlem, and LAM are predominant lineages among clin-
ical isolates ofM. tuberculosis in Guadalajara, Mexico. Clustering rates indicated low trans-
mission of MDR strains. We detected a rare Beijing genotype, SIT406, which was a highly
resistant strain. This is the first report of this Beijing genotype in Latin America.
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Introduction
It is estimated that a third of the world’s population is infected withMycobacterium tuberculo-
sis and over 9 million new tuberculosis (TB) cases are diagnosed annually [1]. In Mexico, more
than 2000 people die every year from TB, and the rate is 16.8 cases per 100,000 in 2010. In the
western state of Jalisco, the TB rate was 13 per 100,000 [2]. Multidrug-resistant strains of
M. tuberculosis (MDR-TB) resistant to isoniazid (INH) and rifampicin (RIF) are a challenge
for clinicians. Patients with MDR-TB are significantly more difficult to treat and mortality is
higher than in drug-susceptible cases [3].
Genotyping has been used to study TB transmission [4,5]. One genotyping technique is re-
striction fragment length polymorphism (RFLP) analysis, where the distribution and number
of copies of an insertion sequence, IS6110, in a chromosome is monitored, and this event varies
among different strains. Spoligotyping is based on polymorphisms in the direct repeat (DR)
locus of theM. tuberculosis genome. Identification of identical genotypes from different pa-
tients generally indicates recent infection by a common source [6], although this greatly de-
pends on the genotyping method used. Spoligotyping has gained international approval as a
robust, fast, and reproducible typing method suitable for epidemiological research [7].
Several studies have reported the genetic diversity ofM. tuberculosis strains in Mexico, but
little information is available from the state of Jalisco [8–17]. Previously we evaluated pheno-
typic and genotypic resistance ofM. tuberculosis isolates from Guadalajara, Jalisco [18]. There-
fore, the aim of this study was to analyze the genetic diversity ofM. tuberculosis clinical isolates
from patients with pulmonary TB in Guadalajara, Jalisco. Shared types, clade predominance,
and clustering rates of both susceptible and MDR isolates were determined.
Methods
Ethics Statement
The local ethics committee (Comité de Ética y Comité de Investigación, Facultad deMedicina y
Hospital “Dr José Eleuterio González”, Universidad Autónoma de Nuevo León, Mexico) approved
the study and written informed consent to participate in this study was obtained from each patient.
Clinical specimens and isolates
The Hospital Civil de Guadalajara, Fray Antonio Alcalde, admitted more than 240 patients
with TB between 2005 and 2011, mostly patients from Jalisco and the surrounding Western
states. From September 2010 to November 2011, specimens (n = 351) were referred to the col-
laborative mycobacteriology laboratory for further testing. All samples were decontaminated
by the Petroff method [19] and cultured on Löwestein-Jensen slants at 37°C. Smears were
made and stained using the Ziehl-Neelsen method and were examined for the presence of acid-
fast bacilli. The cultures were examined twice a week and their growth rates and colony mor-
phologies were recorded. Isolates were identified by traditional biochemical methods including
niacin production and nitrate reduction tests. One isolate per patient was assayed.
DNA isolation and species identification
Mycobacteria were first subjected to enzymatic lysis with lysozyme and proteinase K. DNA
was then obtained using a phenol extraction and ethanol precipitation [20]. Species identifica-
tion was performed using multiplex PCR amplification of the cfp32 (Rv0577), RD9 (Rv2073c)
and RD12 (Rv3120) genes [21,22].
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Drug susceptibility testing
Drug susceptibilities were tested in allM. tuberculosis isolates using the manual Mycobacteria
Growth Indicator Tube (MGIT) method. Critical concentrations of STR (0.8 μg/mL), INH (0.1
μg/mL), RIF (1.0 μg/mL), and EMB (3.5 μg/mL) were used according to the manufacturer’s in-
structions (Becton Dickinson and Co., Sparks Glencoe, MD) [23]. Fluorescence at 365nm indi-
cating microbial growth was detected with a UV light from a transilluminator. The susceptible
H37Ra strain was used as a control.
Spoligotyping analysis
Spoligotyping was performed as described previously [5] using a commercially available kit
(Isogen Life Science, De Meern, Netherlands) according to the manufacturer’s instructions.
Spoligotype results were compared to the SITVITWEB database (available at http://www.
pasteur-guadeloupe.fr:8081/SITVIT_ONLINE/). At the time of the study, SITVITWEB con-
tained 62,582 clinical isolates with 153 countries of origin [7]. A dendrogram of spoligotype
patterns was generated with the unweighted pair group method and the neighbor joining algo-
rithm using the online MIRU-VTRN plus application [24].
IS6110-RFLP analysis
IS6110-RFLP analysis was performed according to the international standard method [4].
Comparison of the results was done using the IBM SPSS statistical software for Windows ver-
sion 20.0 (SPSS Inc, Chicago, IL, USA). Isolates with clustered IS6110-RFLP banding patterns
containing more than five bands were considered related. A dendrogram was generated with
the neighbor joining algorithm using the Jaccard coefficient.
Results
Patients and strains
Clinical samples from 351 patients with pulmonary TB were collected and processed. From
these, 68M. tuberculosis isolates were obtained. Patients were predominantly male (53/68,
77.9%). The median age was 43 years (ranging 1 to 85 years).
Shared types, clades, and clusters ofM. tuberculosis isolates
From the 68 isolates, 31 different spoligotype patterns were detected. Unique spoligotype pat-
terns were detected in 3 strains. They did not match any preexisting patterns in the SITVIT-
WEB database and were considered orphans (Table 1). A total of 27 SITs (including 63
isolates) matched pre-existing SITs in the SITVITWEB database, and one new SIT containing
2 isolates was created in this study (Table 2).
Clustering was detected in 47 isolates (69.1%) (Fig. 1) including SIT53 (T1 of ill-defined T
clade, n = 17, 25.0%), SIT50 (H3 of Haarlem clade, n = 6, 8.8%), SIT42 (LAM9 of the Latin
American-Mediterranean clade, n = 5, 7.4%), SIT17 (LAM2, n = 4, 5.9%), SIT1231 (T5, n = 4,
5.9%), SIT137 (X2 of the IS6110-low-banding X clade, n = 3, 4.4%), SIT34 (the S clade, n = 2,
2.9%), SIT47 (H1, n = 2, 2.9%), SIT51 (T1, n = 2, 2.9%), and SIT3434 (Unknown clade, n = 2,
2.9%), which was created in this study. Single patterns were observed in 18 isolates including
SIT2 (H2), SIT19 (EAI2-Manila), SIT20 (LAM1), SIT92 (X3), SIT232 (Unk), SIT335 (Unk),
SIT371 (H3), SIT406 (Beijing), SIT469 (LAM9), SIT478 (X2), SIT535 (T1), SIT732 (T1),
SIT1215 (LAM2), SIT1225 (S), SIT1356 (S), SIT1686 (H1), SIT2007 (T3) and SIT2212 (H3).
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Table 1. Description of orphan strains found in this study.
Strain ID Sex Age Spoligotype Description Octal Code Drug Resistance
MEX47 Male 26 □□□□□□□□□□□□■■■■■□□■■■■□□□□□□□□□□□□□□□□■■■■ 000076360000071 Susceptible
MEX224 Female 38 ■■■■■■■■□□■■■□■■■■■■■■■■■■■■■■■■□□□□■□■■■■■ 776357777760571 RIF Resistant
MEX257 Male 56 ■■■■■■□□□□□□□■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 770037777760771 Susceptible
Orphan strains had spoligotype patterns that did not match a preexisting pattern in the SITVITWEB database.
doi:10.1371/journal.pone.0118095.t001
Table 2. Description of shared types found in this study.
SITa Spoligotype Description Octal Code Cladeb n (%)
2 □□□□□□□□□□□□□□□□□□□□□□□□■□□□□□□■□□□□■■■■■■■ 000000004020771 H2 1 (1.5)
17 ■■□■■■■■■■■■□■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 677737607760771 LAM2 4 (5.9)
19 ■■□■■■■■■■■■■■■■■■■□□■■■■■■■□□□□■□■■■■■■■■■ 677777477413771 EAI2-Manila 1 (1.5)
20 ■■□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 677777607760771 LAM1 1 (1.5)
34 ■■■■■■■■□□□□■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 776377777760771 S 2 (2.9)
42 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 777777607760771 LAM9 5 (7.4)
47 ■■■■■■■■■■■■■■■■■■■■■■■■□□□□□□□■□□□□■■■■■■■ 777777774020771 H1 2 (2.9)
50 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□■□□□□■■■■■■■ 777777777720771 H3 6 (8.8)
51 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■□□□□ 777777777760700 T1 2 (2.9)
53 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■■ 777777777760771 T1 17 (25)
92 ■■■□□□□□□□□□■■■■■□■■■■■■■■■■■■■■□□□□■■■■■■■ 700076777760771 X3 1 (1.5)
137 ■■■■■■■■■■■■■■■■■□■■■■■■■■■■■■■■□□□□■■□□□□■ 777776777760601 X2 3 (4.4)
232 ■■■■■■■■■■■■■■■■■■■■■■□□□□□□□□□□□□□□□■■■■■■ 777777760000171 Unk 1 (1.5)
335 ■■■■■■■■■■■■■■■■■■■■□□□□■■■■■■□■□□□□■■■■■■■ 777777607720771 Unk 1 (1.5)
371 ■■■■■■■■■■■■■■■■■■□□□□□□■■■■■■□■□□□□■■■■■■■ 777777007720771 H3 1 (1.5)
406 □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□■■■□■■■ 000000000000731 Beijing 1 (1.5)
469 □□□■■■■■■■■■■■■■■■■■□□□□■■■■■■■■□□□□■■■■■■■ 077777607760771 LAM9 1 (1.5)
478 ■■□□□■■■■■■■■■■■■□■■■■■■■■■■■■■■□□□□■■□□□□■ 617776777760601 X2 1 (1.5)
535 ■■■■■■■■■■■■■■■■■■■■■□□□■■■■■■■■□□□□■■■■■■■ 777777707760771 T1 1 (1.5)
732 ■■■■■■■■■■■■■■□□■■■■■■■■■■■■■■■■□□□□■■■■■■■ 777763777760771 T1 1 (1.5)
1215 ■■□■■■■■■■■■□■■■□■■■□□□□■■■■■■■■□□□□■■■■■■■ 677735607760771 LAM2 1 (1.5)
1225 ■■■■■■■■□□■■■■■■■■■■■□□□□□□□□■■■□□□□■■■■■■■ 776377700160771 S 1 (1.5)
1231 ■■■■■■■■■■■■■■■■□□□□□■□■■■■■■■■■□□□□■■■■■■■ 777774057760771 T5 4 (5.9)
1356 ■■■■■■■■□□■■■■■■■■■■■■■■■■■■■■■■□□□□■■■■□■■ 776377777760751 S 1 (1.5)
1686 ■■■■■■■■■■■■■□□□□□□□□□□□■□□□□□□■□□□□■■■■■■■ 777740004020771 H1 1 (1.5)
2007 ■■■■■■■■■■■■□■■■■■■■□■■■■■■■■■■■□□□□■■■■■■■ 777737677760771 T3 1 (1.5)
2212 ■■■■■■■■■■■■■■■■■■■□□□□□■□□■■■□■□□□□■□■■■■■ 777777404720571 H3 1 (1.5)
3434* ■■■■■■■□□■■■■□□□□□□□□□□■□■■■■□■□□□□□■■■■■■■ 774740005720771 Unk 2 (2.9)
aIn the SITVITWEB database, the spoligo (shared) international type (SIT) numbers designate spoligotypes shared by two or more patient isolates.
*SIT3434 is a newly created shared type due to two strains belonging to a new pattern within this study.
bClade designations according to the SITVITWEB database: Beijing clade, East African-Indian (EAI) clade and 9 sublineages, Haarlem (H) clade and 3
sublineages, Latin American-Mediterranean (LAM) clade and 12 sublineages, the ancestral “Manu” family and 3 sublineages, the S clade, the IS6110-low-
banding X clade and 3 sublineages, and an ill-deﬁned T clade with 5 sublineages. Unk, unknown patterns within any of the major clades described in
the database.
doi:10.1371/journal.pone.0118095.t002
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Fig 1. Spoligotype tree ofM. tuberculosis isolates (n = 68). Lineage, Spoligotype International Type (SIT)
as defined in the SITVITWEB proprietary database of the Pasteur Institute of Guadeloupe, and the strain
identifications are shown.
doi:10.1371/journal.pone.0118095.g001
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IS6110-RFLP patterns ofM. tuberculosis isolates
IS6110-RFLP patterns of three isolates (MEX23, MEX33 andMEX82) were not obtained despite
three attempts. The remaining 65 isolates were typified by IS6110-RFLP typing (Fig. 2). We identi-
fied 56 fingerprint patterns, 8 were clustered including 17 isolates with a clustering rate of 26.2%
and the remaining 48 had single patterns. The number of IS6110 copies varied from 1 to 14;
13.8% (n = 9) of the isolates were low-copy-number isolates having less than six copies of IS6110.
Combination of IS6110-RFLP and spoligotyping reduced the number of clustered isolates to 13
and the clustering rate to 20.0%. Isolates lacking the IS6110 element were not observed.
Drug resistantM. tuberculosis isolates
Drug resistance was detected in 33 (48.5%) isolates. Among the 13 MDR isolates, SIT53 (n = 3)
and SIT137 (n = 3) were clustered by spoligotyping and only 2 isolates (MEX313 and
MEX318) were clustered by IS6110-RFLP (Fig. 2). The single pattern isolates SIT335 (Unk),
SIT371 (H3), SIT406 (Beijing), SIT469 (LAM9) and SIT2212 (H3) were also MDR.
Discussion
Determining the genetic diversity ofM. tuberculosis strains allows identification of the distinct
M. tuberculosis genotypes responsible for TB in different regions. Genetic variation inM. tuber-
culosis strains contributes to the variability in disease presentation, frequency of transmission,
and treatment outcomes [25,26]. Knowing these factors is important for appropriate treatment
and control of TB.
The most predominant clades found in our study were the ill-defined T clade (SIT53), the
Haarlem clade (SIT50), the Latin American-Mediterranean clade (SIT42) and the IS6110-low-
banding X clade (SIT137). These results are similar to those reported in several studies from
across the country [8–17]. And considering that SIT42 evolved originally from SIT53, this
group is very dominant in this region [27].
We detected high clustering rates of spoligotypes (69.1%) consistent with previous reports in
Mexico [9,11–13]. However, despite the single spoligopattern presented, four isolates (MEX2,
MEX3, MEX220 and MEX240) were in 2 clusters according to IS6110-RFLP. Thus, combina-
tion of IS6110-RFLP and spoligotyping reduced the clustering rate to 20.0%. This indicates that
spoligotyping alone is not discriminatory enough to determine epidemiological links and for
transmission analysis, due to the high rate of homoplasy (independent mutational events that
result in the loss of the same spacer) exhibited by the spacers used in spoligotyping [28–30].
The low clustering rate detected in this study indicates low transmission ofM. tuberculosis
clones. Most of the clustered isolates, regardless of genotypic family, were drug susceptible, also
indicating low transmission of MDR isolates. In addition, changes in the drug resistance pat-
tern of the isolates in one cluster were not accompanied by changes of the IS6110-RFLP pattern
(clusters 1, 2, 3, 5 and 7). This is in accordance with previous studies where the rate of change
of IS6110 fingerprint patterns in drug-resistant isolates seems not to differ from that in drug-
susceptible isolates, thus indicating a high degree of stability of IS6110 patterns [31–33].
Although a high number of previously reported spoligotypes were identified in Mexico
[12,13,17], 19.1% of our isolates showed SIT (335, 371, 406, 469, 1231, 1686, 2007, 2212 and
3434) which were previously unreported in the country.
M. tuberculosis isolates with no IS6110 elements are rare [34] and we did not find them in
Jalisco. In Mexico, there is only one report in Mexico City, constituting as high as 20% of the
isolates studied [13]. It will be important to determine the ancestry of these patients, since zero
IS6110 M. tuberculosis isolates have been found elsewhere in Mexico.
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Fig 2. IS6110-RFLP clustering patterns, spoligopatterns and drug resistance profiles ofM. tuberculosis isolates.Drug resistance profile indicates
resistance to I: isoniazid; R: rifampicin; S: streptomycin and E: ethambutol.
doi:10.1371/journal.pone.0118095.g002
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Some M. tuberculosis strains of the Beijing genotype have been often associated with
MDR phenotype and higher transmission compared to other genotypes [26,35]. The Bei-
jing genotype is principally identified by the deletion of spacers 1–34 and the presence of
at least 3 of the 9 spacers between positions 35 and 43 of the DR locus [36–38]. To date,
27 Beijing family genotypes have been reported in the STVIT2 international database (in-
cluding 6,148 strains from 71 countries). SIT1 was the classical Beijing genotype in the
SITVITWEB database at the time this study was conducted. Although these strains are
prevalent throughout Asia, they are found worldwide [39]. The SIT1 genotype has been
reported in several states in Mexico including Puebla [14], Jalisco [9], Baja California,
Sinaloa, Veracruz [15] and San Luis Potosi [16]. Both drug-susceptible and resistant
strains have been documented.
In this study, we detected an MDR strain with the Beijing genotype and a SIT406 pat-
tern. To our knowledge, this is the first report of Beijing SIT406 in Mexico or Latin Amer-
ica. At the time of this comparison, SIT406 represented a total of 14 strains in the
SITVITWEB database, which corresponded to 0.2% (14/6,148) of all Beijing strains, in
contrast to SIT1, which corresponded to 94.3% (5,800/6,148) of all Beijing strains. Ac-
cording to the available entries from the database, the distribution of SIT406 strains is
limited to the United States (64.3%), Belgium, India, Italy, Japan, and Tunisia (7.1% each).
Little is known about the differences between disease caused by the rare Beijing and
classical Beijing genotypes. In Latin America only two rare Beijing strains have been re-
ported in Mexico (SIT269 and SIT941) [7] and one case was reported in Colombia
(SIT190) [40]. TB treatment outcomes are associated with MDR phenotypes rather than
Beijing genotypes [41]. However, most studies of Beijing strains only include SIT1 strains,
and the behavior of other Beijing family genotypes is undefined. Spoligotyping is com-
monly used in high-income countries and data from countries such as Mexico is limited.
One limitation of this work is the lack of use of mycobacterium interspersed repetitive
unit-variable number of tandem repeat (MIRU-VNTR) as a genotyping method for
M. tuberculosis isolates. It is well known that in the M. tuberculosis epidemiology, MIRU-
VNTR and spoligotyping are increasingly being used as first line methods for their ease,
discriminatory power, and digital analysis of generated data [6] compared with the gold
standard IS6110 typing method. Nonetheless, MIRU-VNTR genotyping is commonly
used in high-income countries and availability in countries such as Mexico is limited. In-
cidentally, it has been reported a reduced discriminatory power of 24-loci MIRU-VNTR
compared to IS6110 typing especially in Beijing lineages [42,43]. In these cases, 24-loci
MIRU-VNTR typing is inadequate for accurately identifying transmission chains of Bei-
jing strains, and thus needs to be complemented either by IS6110 typing or combinations
of MIRU-VNTR loci more variable in Beijing strains [43]. Contrariwise, MIRU-VNTR al-
lows a higher discrimination of the low-copy-number isolates, which in our case corre-
sponded to 13.8% of the isolates studied. Therefore, an expansion of this work is required
to further analyze this isolates using MIRU-VNTR, both to allow the inclusion of a greater
sample number and to further describe the Beijing genotype detected in this study.
In summary, T, Haarlem, and LAM were predominant lineages in clinical isolates of
M. tuberculosis in Guadalajara, Jalisco. Transmission of MDR strains was low in Guadala-
jara. However, some isolated cases of TB were caused by the rare MDR Beijing genotype.
The report of an MDR strain with a SIT406 pattern indicated additional effort should be
placed on the search for these genotypes. The status of Beijing strains in Mexico needs to
be monitored to determine whether they are expanding.
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